- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Ash Blythe Alpert, MD, MFA
they/them/theirs
Leukemia & Lymphoma, Hematologic Oncology
Telehealth is available
Patient type treated
Adult
Accepting new patients
Yes
Referral required
Not Applicable
Board Certified in
Internal Medicine and Hematology (Internal Medicine)
Titles
- Instructor
- Member, Cancer Prevention and Control
Education & Training
- MDUniversity of Vermont Larner College of Medicine (2014)
- MFAWestern Michigan University (2004)
- BAOberlin College (1998)
Additional Information
Board Certifications
- AB of Internal Medicine, Hematology (Internal Medicine) (2022)
- AB of Internal Medicine, Internal Medicine (2017)
Publications
- Alpert A, Hernandez T, Ruddick R, Manzano C, Adams S, Rivers L, Ramos-Pibernus A, Sevelius J, Poteat T, Obedin-Maliver J, Cicero E, Radix A, Lett E, Operario D, Chapman B, Wittink M, Cupertino A, Murchison G, Nunez-Smith M, Cartujano-Barrera F. Disentangling gender, sex, and biology: a mixed methods study of gender identity data collection tools. Patient Education And Counseling 2024, 130: 108473. PMID: 39471780, DOI: 10.1016/j.pec.2024.108473.
- Alpert A, Obedin-Maliver J, Gjelsvik A, Amanullah S, Shireman T, Blosnich J. Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people? Contemporary Clinical Trials 2024, 146: 107695. PMID: 39303766, DOI: 10.1016/j.cct.2024.107695.
- Alpert A, Sayegh S, Cunliffe S, Sevelius J, Operario D, Pachankis J, Irwin M, Cerulli C, Griggs J, Strawderman M. Associations between violence, distress, and cancer in transgender and non-transgender people. Journal Of Clinical Oncology 2024, 42: 10566-10566. DOI: 10.1200/jco.2024.42.16_suppl.10566.
- Alpert A, Babbs G, Sanaeikia R, Ellison J, Hughes L, Herington J, Dembroff R. Doing Justice: Ethical Considerations Identifying and Researching Transgender and Gender Diverse People in Insurance Claims Data. Journal Of Medical Systems 2024, 48: 96. PMID: 39394534, PMCID: PMC11469973, DOI: 10.1007/s10916-024-02111-w.
- Cartujano-Barrera F, Mejia R, Radusky P, Cardozo N, Duarte M, Fabian S, Caballero R, Zalazar V, Ramos-Pibernus A, Alpert A, Cupertino A, Frola C, Aristegui I. Prevalence and correlates of current cigarette smoking among transgender women in Argentina. Frontiers In Public Health 2023, 11: 1279969. PMID: 38115852, PMCID: PMC10728477, DOI: 10.3389/fpubh.2023.1279969.
- Alpert A, Mehringer J, Orta S, Hernandez T, Redwood E, Rivers L, Manzano C, Ruddick R, Adams S, Sevelius J, Belanger E, Operario D, Griggs J. Transgender People’s Experiences Sharing Information With Clinicians: A Focus Group–Based Qualitative Study. The Annals Of Family Medicine 2023, 21: 408-415. PMID: 37748898, PMCID: PMC10519763, DOI: 10.1370/afm.3010.
- Alpert A, Rivers L, Manzano C, Ruddick R, Adams S, Obedin-Maliver J, Harvey R, Griggs J, Operario D. Debunking Sex and Disentangling Gender From Oncology. Journal Of Clinical Oncology 2023, 41: 3791-3795. PMID: 37235816, PMCID: PMC10860932, DOI: 10.1200/jco.22.02037.
- Freedman-Cass D, Fischer T, Alpert A, Obedin-Maliver J, Kunz P, Koh W, Carlson R. The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN Content. Journal Of The National Comprehensive Cancer Network 2023, 21: 434-441. PMID: 37156485, DOI: 10.6004/jnccn.2023.7025.
- Katz N, Alpert A, Aristizabal M, McDaniels-Davidson C, Sacks B, Sanft T, Chou C, Martinez M. Partnering With Patients and Caregivers in Cancer Care: Lessons From Experiences With Transgender, Hispanic, and Pediatric Populations. American Society Of Clinical Oncology Educational Book 2023, 43: e397264. PMID: 37200592, DOI: 10.1200/edbk_397264.
- Alpert A, Sayegh S, Strawderman M, Cunliffe S, Griggs J, Cerulli C. Methodologic Approaches for Using Electronic Medical Records to Identify Experiences of Violence in Transgender and Cisgender People: Closing the Gap Between Diagnostic Coding and Lived Experiences. Medical Care 2023, 61: 384-391. PMID: 37072686, PMCID: PMC10168107, DOI: 10.1097/mlr.0000000000001852.
- Hughto J, Varma H, Babbs G, Yee K, Alpert A, Hughes L, Ellison J, Downing J, Shireman T. Disparities in health condition diagnoses among aging transgender and cisgender medicare beneficiaries, 2008-2017. Frontiers In Endocrinology 2023, 14: 1102348. PMID: 36992801, PMCID: PMC10040837, DOI: 10.3389/fendo.2023.1102348.
- Kamen C, Reichelt M, Dadgostar P, Alpert A, Doucette C, Vaughan P, Keuroghlian A, Yousefi-Nooraie R. Sexual and gender minority cultural humility training for oncology settings: An example of iterative adaptation and implementation. Frontiers In Health Services 2022, 2: 958274. PMID: 36925900, PMCID: PMC10012625, DOI: 10.3389/frhs.2022.958274.
- Alpert A, Brewer J, Adams S, Rivers L, Orta S, Blosnich J, Miedlich S, Kamen C, Dizon D, Pazdur R, Beaver J, Fashoyin-Aje L. Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data. Journal Of Clinical Oncology 2022, 41: 1825-1829. PMID: 36302204, PMCID: PMC10082226, DOI: 10.1200/jco.22.01174.
- Alpert A, Scout N, Schabath M, Adams S, Obedin-Maliver J, Safer J. Gender- and Sexual Orientation- Based Inequities: Promoting Inclusion, Visibility, and Data Accuracy in Oncology. American Society Of Clinical Oncology Educational Book 2022, 42: 1-17. PMID: 35658501, DOI: 10.1200/edbk_350175.
- Alpert A, Sayegh S, Strawderman M, Cunliffe S, Cupertino A, Griggs J, Cerulli C. Associations between interpersonal violence and cancer risk factors for transgender and cisgender people. Journal Of Clinical Oncology 2022, 40: 6516-6516. DOI: 10.1200/jco.2022.40.16_suppl.6516.
- Alpert A, Sayegh S, Strawderman M, Cunliffe S, Cupertino A, Cerulli C, Griggs J. Cancer risk factors and cancer in transgender versus cisgender people: Real-world data from a tertiary health care institution. Journal Of Clinical Oncology 2022, 40: 6538-6538. DOI: 10.1200/jco.2022.40.16_suppl.6538.
- Alpert A, Mehringer J, Orta S, Redwood E, Hernandez T, Rivers L, Manzano C, Ruddick R, Adams S, Cerulli C, Operario D, Griggs J. Experiences of Transgender People Reviewing Their Electronic Health Records, a Qualitative Study. Journal Of General Internal Medicine 2022, 38: 970-977. PMID: 35641720, PMCID: PMC10039220, DOI: 10.1007/s11606-022-07671-6.
- Alderuccio J, Arcaini L, Watkins M, Beaven A, Shouse G, Epperla N, Spina M, Stefanovic A, Sandoval-Sus J, Torka P, Alpert A, Olszewski A, Kim S, Hess B, Gaballa S, Ayyappan S, Castillo J, Argnani L, Voorhees T, Saba R, Chowdhury S, Vargas F, Reis I, Kwon D, Alexander J, Zhao W, Edwards D, Martin P, Cencini E, Kamdar M, Link B, Logothetis C, Herrera A, Friedberg J, Kahl B, Luminari S, Zinzani P, Lossos I. An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood Advances 2022, 6: 2035-2044. PMID: 35196377, PMCID: PMC9006265, DOI: 10.1182/bloodadvances.2021006844.
- Hughto J, Hughes L, Yee K, Downing J, Ellison J, Alpert A, Jasuja G, Shireman T. Improving Data-Driven Methods to Identify and Categorize Transgender Individuals by Gender in Insurance Claims Data. LGBT Health 2022, 9: 254-263. PMID: 35290746, PMCID: PMC9150133, DOI: 10.1089/lgbt.2021.0433.
- Cartujano-Barrera F, Cox L, Catley D, Shah Z, Alpert A, Cupertino A. “I'm a transgender man… I have to quit smoking for treatment and surgery”: Describing the experience of a Latino transgender man during his attempt to quit smoking. Explore: The Journal Of Science & Healing 2021, 19: 131-135. PMID: 34823998, PMCID: PMC9110554, DOI: 10.1016/j.explore.2021.11.005.
- Alpert A, Torres N, Snyder E, Rock P, Adlowitz D, Peterson D, Cupertino P, Casulo C, Burack R. Regional Differences in Lymphomagenesis Identified through Quantification of AICDA-Mediated Subclonal Evolution in Follicular Lymphoma: Do Pesticides Play a Role? Blood 2021, 138: 3505. DOI: 10.1182/blood-2021-146972.
- Pratt-Chapman M, Alpert A, Castillo D. Health outcomes of sexual and gender minorities after cancer: a systematic review. Systematic Reviews 2021, 10: 183. PMID: 34154645, PMCID: PMC8218456, DOI: 10.1186/s13643-021-01707-4.
- Alpert A, Ruddick R, Manzano C. Rethinking sex-assigned-at-birth questions. The BMJ 2021, 373: n1261. PMID: 34031025, DOI: 10.1136/bmj.n1261.
- Alpert A, Gampa V, Vadaparampil S, Quinn G. Trainings needs of allied health professionals caring for sexual and gender minority adolescents and young adults with cancer: A qualitative analysis. Journal Of Clinical Oncology 2021, 39: e18532-e18532. DOI: 10.1200/jco.2021.39.15_suppl.e18532.
- Alpert A, Moftakhar B. Confidence. Journal Of Clinical Oncology 2021, 39: 2410-2412. PMID: 33979204, DOI: 10.1200/jco.21.00012.
- Alpert A, Gampa V, Lytle M, Manzano C, Ruddick R, Poteat T, Quinn G, Kamen C. I’m not putting on that floral gown: Enforcement and resistance of gender expectations for transgender people with cancer. Patient Education And Counseling 2021, 104: 2552-2558. PMID: 33745786, PMCID: PMC9320277, DOI: 10.1016/j.pec.2021.03.007.
- Alpert A, Komatsoulis G, Meersman S, Garrett-Mayer E, Bruinooge S, Miller R, Potter D, Koronkowski B, Stepanski E, Dizon D. Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ Observations. JCO Oncology Practice 2021, 17: e336-e342. PMID: 33705680, DOI: 10.1200/op.20.00634.
- Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International AnalysisAlderuccio J, Beaven A, Shouse G, Epperla N, Stefanovic A, Torka P, Castillo J, Argnani L, Voorhees T, Alpert A, Chowdhury S, Reis I, Zhao W, Edwards D, Martin P, Kamdar M, Herrera A, Friedberg J, Zinzani P, Lossos I. Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International Analysis. Blood 2020, 136: 2-3. DOI: 10.1182/blood-2020-137620.
- Quinn G, Sampson A, Alpert A, Toledo R, Sutter M, Lake P, Schabath M, Vadaparampil S. CLINICIAN TRAINING NEEDS IN REPRODUCTIVE HEALTH COUNSELING FOR SEXUAL AND GENDER MINORITY AYA WITH CANCER. Fertility And Sterility 2020, 114: e540-e541. DOI: 10.1016/j.fertnstert.2020.09.073.
- Alpert A, O'Dwyer K. Allogeneic HSCT After PD-1 Blockade: Has Post-transplant Cyclophosphamide Rendered Checkpoint Inhibition a Safe Bridge to Allogeneic Stem Cell Transplantation? The Hematologist 2020, 17 DOI: 10.1182/hem.v17.4.12884901916.
- Alpert A, Kamen C, Schabath M, Hamel L, Seay J, Quinn G. What Exactly Are We Measuring? Evaluating Sexual and Gender Minority Cultural Humility Training for Oncology Care Clinicians. Journal Of Clinical Oncology 2020, 38: 2605-2609. PMID: 32552279, PMCID: PMC7402994, DOI: 10.1200/jco.19.03300.
- Quinn G, Alpert A, Sutter M, Schabath M. What Oncologists Should Know About Treating Sexual and Gender Minority Patients With Cancer. JCO Oncology Practice 2020, 16: 309-316. PMCID: PMC7291539, DOI: 10.1200/op.20.00036.
- Alpert A, Tarras E, Sampson A, Strawderman M, Sutter M, Quinn G. Responding to narrowing discrimination protections: Can hospital policies protect transgender and gender diverse patients with cancer? Journal Of Clinical Oncology 2020, 38: e14126-e14126. DOI: 10.1200/jco.2020.38.15_suppl.e14126.
- Alpert A, Bruinooge S, Dizon D, Koronkowski B, Garrett-Mayer E, Meersman S, Miller R, Potter D, Komatsoulis G. Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations. Journal Of Clinical Oncology 2020, 38: e19046-e19046. DOI: 10.1200/jco.2020.38.15_suppl.e19046.
- Tarras E, Alpert A, Kennedy E, Sampson A, Sutter M, Quinn G. Protecting Transgender and Gender-Diverse Patients With Cancer in a Shifting Political Landscape. JCO Oncology Practice 2020, 16: 287-288. PMID: 32119594, PMCID: PMC7291541, DOI: 10.1200/jcoop.20.00011.
- Alpert A. Coming Out in the Exam Room. Journal Of Clinical Oncology 2020, 38: 1246-1247. PMID: 32045543, DOI: 10.1200/jco.19.01428.
Departments and Programs
Locations
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Titles
- Instructor
- Member, Cancer Prevention and Control
Education & Training
- MDUniversity of Vermont Larner College of Medicine (2014)
- MFAWestern Michigan University (2004)
- BAOberlin College (1998)
Additional Information
Board Certifications
- AB of Internal Medicine, Hematology (Internal Medicine) (2022)
- AB of Internal Medicine, Internal Medicine (2017)
Publications
- Alpert A, Hernandez T, Ruddick R, Manzano C, Adams S, Rivers L, Ramos-Pibernus A, Sevelius J, Poteat T, Obedin-Maliver J, Cicero E, Radix A, Lett E, Operario D, Chapman B, Wittink M, Cupertino A, Murchison G, Nunez-Smith M, Cartujano-Barrera F. Disentangling gender, sex, and biology: a mixed methods study of gender identity data collection tools. Patient Education And Counseling 2024, 130: 108473. PMID: 39471780, DOI: 10.1016/j.pec.2024.108473.
- Alpert A, Obedin-Maliver J, Gjelsvik A, Amanullah S, Shireman T, Blosnich J. Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people? Contemporary Clinical Trials 2024, 146: 107695. PMID: 39303766, DOI: 10.1016/j.cct.2024.107695.
- Alpert A, Sayegh S, Cunliffe S, Sevelius J, Operario D, Pachankis J, Irwin M, Cerulli C, Griggs J, Strawderman M. Associations between violence, distress, and cancer in transgender and non-transgender people. Journal Of Clinical Oncology 2024, 42: 10566-10566. DOI: 10.1200/jco.2024.42.16_suppl.10566.
- Alpert A, Babbs G, Sanaeikia R, Ellison J, Hughes L, Herington J, Dembroff R. Doing Justice: Ethical Considerations Identifying and Researching Transgender and Gender Diverse People in Insurance Claims Data. Journal Of Medical Systems 2024, 48: 96. PMID: 39394534, PMCID: PMC11469973, DOI: 10.1007/s10916-024-02111-w.
- Cartujano-Barrera F, Mejia R, Radusky P, Cardozo N, Duarte M, Fabian S, Caballero R, Zalazar V, Ramos-Pibernus A, Alpert A, Cupertino A, Frola C, Aristegui I. Prevalence and correlates of current cigarette smoking among transgender women in Argentina. Frontiers In Public Health 2023, 11: 1279969. PMID: 38115852, PMCID: PMC10728477, DOI: 10.3389/fpubh.2023.1279969.
- Alpert A, Mehringer J, Orta S, Hernandez T, Redwood E, Rivers L, Manzano C, Ruddick R, Adams S, Sevelius J, Belanger E, Operario D, Griggs J. Transgender People’s Experiences Sharing Information With Clinicians: A Focus Group–Based Qualitative Study. The Annals Of Family Medicine 2023, 21: 408-415. PMID: 37748898, PMCID: PMC10519763, DOI: 10.1370/afm.3010.
- Alpert A, Rivers L, Manzano C, Ruddick R, Adams S, Obedin-Maliver J, Harvey R, Griggs J, Operario D. Debunking Sex and Disentangling Gender From Oncology. Journal Of Clinical Oncology 2023, 41: 3791-3795. PMID: 37235816, PMCID: PMC10860932, DOI: 10.1200/jco.22.02037.
- Freedman-Cass D, Fischer T, Alpert A, Obedin-Maliver J, Kunz P, Koh W, Carlson R. The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN Content. Journal Of The National Comprehensive Cancer Network 2023, 21: 434-441. PMID: 37156485, DOI: 10.6004/jnccn.2023.7025.
- Katz N, Alpert A, Aristizabal M, McDaniels-Davidson C, Sacks B, Sanft T, Chou C, Martinez M. Partnering With Patients and Caregivers in Cancer Care: Lessons From Experiences With Transgender, Hispanic, and Pediatric Populations. American Society Of Clinical Oncology Educational Book 2023, 43: e397264. PMID: 37200592, DOI: 10.1200/edbk_397264.
- Alpert A, Sayegh S, Strawderman M, Cunliffe S, Griggs J, Cerulli C. Methodologic Approaches for Using Electronic Medical Records to Identify Experiences of Violence in Transgender and Cisgender People: Closing the Gap Between Diagnostic Coding and Lived Experiences. Medical Care 2023, 61: 384-391. PMID: 37072686, PMCID: PMC10168107, DOI: 10.1097/mlr.0000000000001852.
- Hughto J, Varma H, Babbs G, Yee K, Alpert A, Hughes L, Ellison J, Downing J, Shireman T. Disparities in health condition diagnoses among aging transgender and cisgender medicare beneficiaries, 2008-2017. Frontiers In Endocrinology 2023, 14: 1102348. PMID: 36992801, PMCID: PMC10040837, DOI: 10.3389/fendo.2023.1102348.
- Kamen C, Reichelt M, Dadgostar P, Alpert A, Doucette C, Vaughan P, Keuroghlian A, Yousefi-Nooraie R. Sexual and gender minority cultural humility training for oncology settings: An example of iterative adaptation and implementation. Frontiers In Health Services 2022, 2: 958274. PMID: 36925900, PMCID: PMC10012625, DOI: 10.3389/frhs.2022.958274.
- Alpert A, Brewer J, Adams S, Rivers L, Orta S, Blosnich J, Miedlich S, Kamen C, Dizon D, Pazdur R, Beaver J, Fashoyin-Aje L. Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data. Journal Of Clinical Oncology 2022, 41: 1825-1829. PMID: 36302204, PMCID: PMC10082226, DOI: 10.1200/jco.22.01174.
- Alpert A, Scout N, Schabath M, Adams S, Obedin-Maliver J, Safer J. Gender- and Sexual Orientation- Based Inequities: Promoting Inclusion, Visibility, and Data Accuracy in Oncology. American Society Of Clinical Oncology Educational Book 2022, 42: 1-17. PMID: 35658501, DOI: 10.1200/edbk_350175.
- Alpert A, Sayegh S, Strawderman M, Cunliffe S, Cupertino A, Griggs J, Cerulli C. Associations between interpersonal violence and cancer risk factors for transgender and cisgender people. Journal Of Clinical Oncology 2022, 40: 6516-6516. DOI: 10.1200/jco.2022.40.16_suppl.6516.
- Alpert A, Sayegh S, Strawderman M, Cunliffe S, Cupertino A, Cerulli C, Griggs J. Cancer risk factors and cancer in transgender versus cisgender people: Real-world data from a tertiary health care institution. Journal Of Clinical Oncology 2022, 40: 6538-6538. DOI: 10.1200/jco.2022.40.16_suppl.6538.
- Alpert A, Mehringer J, Orta S, Redwood E, Hernandez T, Rivers L, Manzano C, Ruddick R, Adams S, Cerulli C, Operario D, Griggs J. Experiences of Transgender People Reviewing Their Electronic Health Records, a Qualitative Study. Journal Of General Internal Medicine 2022, 38: 970-977. PMID: 35641720, PMCID: PMC10039220, DOI: 10.1007/s11606-022-07671-6.
- Alderuccio J, Arcaini L, Watkins M, Beaven A, Shouse G, Epperla N, Spina M, Stefanovic A, Sandoval-Sus J, Torka P, Alpert A, Olszewski A, Kim S, Hess B, Gaballa S, Ayyappan S, Castillo J, Argnani L, Voorhees T, Saba R, Chowdhury S, Vargas F, Reis I, Kwon D, Alexander J, Zhao W, Edwards D, Martin P, Cencini E, Kamdar M, Link B, Logothetis C, Herrera A, Friedberg J, Kahl B, Luminari S, Zinzani P, Lossos I. An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood Advances 2022, 6: 2035-2044. PMID: 35196377, PMCID: PMC9006265, DOI: 10.1182/bloodadvances.2021006844.
- Hughto J, Hughes L, Yee K, Downing J, Ellison J, Alpert A, Jasuja G, Shireman T. Improving Data-Driven Methods to Identify and Categorize Transgender Individuals by Gender in Insurance Claims Data. LGBT Health 2022, 9: 254-263. PMID: 35290746, PMCID: PMC9150133, DOI: 10.1089/lgbt.2021.0433.
- Cartujano-Barrera F, Cox L, Catley D, Shah Z, Alpert A, Cupertino A. “I'm a transgender man… I have to quit smoking for treatment and surgery”: Describing the experience of a Latino transgender man during his attempt to quit smoking. Explore: The Journal Of Science & Healing 2021, 19: 131-135. PMID: 34823998, PMCID: PMC9110554, DOI: 10.1016/j.explore.2021.11.005.
- Alpert A, Torres N, Snyder E, Rock P, Adlowitz D, Peterson D, Cupertino P, Casulo C, Burack R. Regional Differences in Lymphomagenesis Identified through Quantification of AICDA-Mediated Subclonal Evolution in Follicular Lymphoma: Do Pesticides Play a Role? Blood 2021, 138: 3505. DOI: 10.1182/blood-2021-146972.
- Pratt-Chapman M, Alpert A, Castillo D. Health outcomes of sexual and gender minorities after cancer: a systematic review. Systematic Reviews 2021, 10: 183. PMID: 34154645, PMCID: PMC8218456, DOI: 10.1186/s13643-021-01707-4.
- Alpert A, Ruddick R, Manzano C. Rethinking sex-assigned-at-birth questions. The BMJ 2021, 373: n1261. PMID: 34031025, DOI: 10.1136/bmj.n1261.
- Alpert A, Gampa V, Vadaparampil S, Quinn G. Trainings needs of allied health professionals caring for sexual and gender minority adolescents and young adults with cancer: A qualitative analysis. Journal Of Clinical Oncology 2021, 39: e18532-e18532. DOI: 10.1200/jco.2021.39.15_suppl.e18532.
- Alpert A, Moftakhar B. Confidence. Journal Of Clinical Oncology 2021, 39: 2410-2412. PMID: 33979204, DOI: 10.1200/jco.21.00012.
- Alpert A, Gampa V, Lytle M, Manzano C, Ruddick R, Poteat T, Quinn G, Kamen C. I’m not putting on that floral gown: Enforcement and resistance of gender expectations for transgender people with cancer. Patient Education And Counseling 2021, 104: 2552-2558. PMID: 33745786, PMCID: PMC9320277, DOI: 10.1016/j.pec.2021.03.007.
- Alpert A, Komatsoulis G, Meersman S, Garrett-Mayer E, Bruinooge S, Miller R, Potter D, Koronkowski B, Stepanski E, Dizon D. Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ Observations. JCO Oncology Practice 2021, 17: e336-e342. PMID: 33705680, DOI: 10.1200/op.20.00634.
- Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International AnalysisAlderuccio J, Beaven A, Shouse G, Epperla N, Stefanovic A, Torka P, Castillo J, Argnani L, Voorhees T, Alpert A, Chowdhury S, Reis I, Zhao W, Edwards D, Martin P, Kamdar M, Herrera A, Friedberg J, Zinzani P, Lossos I. Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International Analysis. Blood 2020, 136: 2-3. DOI: 10.1182/blood-2020-137620.
- Quinn G, Sampson A, Alpert A, Toledo R, Sutter M, Lake P, Schabath M, Vadaparampil S. CLINICIAN TRAINING NEEDS IN REPRODUCTIVE HEALTH COUNSELING FOR SEXUAL AND GENDER MINORITY AYA WITH CANCER. Fertility And Sterility 2020, 114: e540-e541. DOI: 10.1016/j.fertnstert.2020.09.073.
- Alpert A, O'Dwyer K. Allogeneic HSCT After PD-1 Blockade: Has Post-transplant Cyclophosphamide Rendered Checkpoint Inhibition a Safe Bridge to Allogeneic Stem Cell Transplantation? The Hematologist 2020, 17 DOI: 10.1182/hem.v17.4.12884901916.
- Alpert A, Kamen C, Schabath M, Hamel L, Seay J, Quinn G. What Exactly Are We Measuring? Evaluating Sexual and Gender Minority Cultural Humility Training for Oncology Care Clinicians. Journal Of Clinical Oncology 2020, 38: 2605-2609. PMID: 32552279, PMCID: PMC7402994, DOI: 10.1200/jco.19.03300.
- Quinn G, Alpert A, Sutter M, Schabath M. What Oncologists Should Know About Treating Sexual and Gender Minority Patients With Cancer. JCO Oncology Practice 2020, 16: 309-316. PMCID: PMC7291539, DOI: 10.1200/op.20.00036.
- Alpert A, Tarras E, Sampson A, Strawderman M, Sutter M, Quinn G. Responding to narrowing discrimination protections: Can hospital policies protect transgender and gender diverse patients with cancer? Journal Of Clinical Oncology 2020, 38: e14126-e14126. DOI: 10.1200/jco.2020.38.15_suppl.e14126.
- Alpert A, Bruinooge S, Dizon D, Koronkowski B, Garrett-Mayer E, Meersman S, Miller R, Potter D, Komatsoulis G. Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations. Journal Of Clinical Oncology 2020, 38: e19046-e19046. DOI: 10.1200/jco.2020.38.15_suppl.e19046.
- Tarras E, Alpert A, Kennedy E, Sampson A, Sutter M, Quinn G. Protecting Transgender and Gender-Diverse Patients With Cancer in a Shifting Political Landscape. JCO Oncology Practice 2020, 16: 287-288. PMID: 32119594, PMCID: PMC7291541, DOI: 10.1200/jcoop.20.00011.
- Alpert A. Coming Out in the Exam Room. Journal Of Clinical Oncology 2020, 38: 1246-1247. PMID: 32045543, DOI: 10.1200/jco.19.01428.
Departments and Programs
Locations
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511